• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.06% Nasdaq Up 0.42%

    More On IMV.V

    Quotes

    Charts

    News & Info

    Company

    • Profile
    • Key Statistics
    • SEC Filings
    • Competitors
    • Industry
    • Components

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    ImmunoVaccine Inc. (IMV.V)

    -TSXV
    0.73 Up 0.01(1.39%) Nov 25
    Add to Portfolio
    Prev Close:0.72
    Open:0.73
    Bid:0.70
    Ask:0.73
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.68 - 0.73
    52wk Range:0.30 - 1.50
    Volume:73,405
    Avg Vol (3m):344,580
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-0.07
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in CAD.

    Headlines

    » More Headlines for IMV.V

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (0-00-31) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immunovaccine Inc., a clinical-stage biopharmaceutical company, discovers and develops activators of the immune system to treat cancer and prevent infectious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback